Please login to the form below

Not currently logged in
Email:
Password:

Scottish Medicines Consortium

This page shows the latest Scottish Medicines Consortium news and features for those working in and with pharma, biotech and healthcare.

Novartis gets EU nod for Luxturna gene therapy

Novartis gets EU nod for Luxturna gene therapy

therapy” and that decisions from national reimbursement bodies – including NICE and the Scottish Medicines Consortium – “are expected in 2019 and 2020.”.

Latest news

More from news
Approximately 4 fully matching, plus 80 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    December 2018: Scottish Government agrees a deal with Vertex pending submission of Orkambi and Symkevi to Scottish Medicines Consortium (SMC), with interim access possible through the PACS Tier 2 system. ... March 2019: Vertex, NHSE and NICE meet with

  • The reality of real-world evidence The reality of real-world evidence

    Zaltrap re-submission to the Scottish Medicines Consortium (SMC) included RWE (pooled data from two open-label, single-arm studies) to demonstrate prolonged safety and QoL benefit.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics